Eastern Bank
IONS icon

Eastern Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Eastern Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.4K Hold
300
– – ﹤0.01% 880
2026
Q2 		$23.8K Hold
300
– – ﹤0.01% 740
2026
Q1 		$22.5K Hold
300
– – ﹤0.01% 697
2025
Q4 		$23.7K Hold
300
– – ﹤0.01% 697
2025
Q3 		$19.6K Hold
300
– – ﹤0.01% 730
2025
Q2 		$11.9K Hold
300
– – ﹤0.01% 738
2025
Q1 		$9.05K Buy
+300
New +$9.8K ﹤0.01% 798

Other funds holding IONS

Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Nicollet Investment Management
Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Eastern Bank's IONS Position: Q3 2026 in Review

Eastern Bank held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 300 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Eastern Bank first reported a position in IONS in Q1 2025 and has held it in 7 quarters since. The position peaked at $23.8K in Q2 2026. 60 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Eastern Bank held 300 shares of Ionis Pharmaceuticals worth $13.4K as of Q3 2026.
  • Eastern Bank left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #880 holding.
  • Eastern Bank first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Eastern Bank's Ionis Pharmaceuticals position peaked at $23.8K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.